Ruxience 500 MG/50 ML vial 50ML
Ended Awarded
- Contract number
- SPE2DR26FQN7Y
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $4,951
Award facts
- Contract value 100% obligated
- $4,950.90 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $4,950.90 to AmerisourceBergen Drug Corp for Ruxience 500 mg/50 ml vials on October 29, 2025, with completion expected by October 30, 2025. This firm fixed price delivery order represents a competitive award with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Ruxience is a biosimilar to rituximab used in treating various cancers and autoimmune conditions, reflecting the Defense Logistics Agency's ongoing procurement of critical pharmaceutical products to support military and federal healthcare systems.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and critical federal medical supplier, AmerisourceBergen Drug Corp maintains an extensive portfolio of drug and medical supply deliveries across the Defense Logistics Agency's medical supply chain, serving the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The company's contract awards demonstrate consistent capability to fulfill federal procurement requirements through open competition across diverse therapeutic domains and transaction values.
Quick answers
Who was awarded contract SPE2DR26FQN7Y?
SPE2DR26FQN7Y was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 29, 2025.
How much is contract SPE2DR26FQN7Y worth?
The government has obligated $4,951 on SPE2DR26FQN7Y.
Is contract SPE2DR26FQN7Y an order under another contract?
Yes. SPE2DR26FQN7Y is a delivery order under SPE2DR25D1022, an indefinite delivery contract.
Was contract SPE2DR26FQN7Y competed?
The extent of competition for SPE2DR26FQN7Y was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award